Immunocore Holdings (IMCR) Receivables: 2021-2025
Historic Receivables for Immunocore Holdings (IMCR) over the last 2 years, with Sep 2025 value amounting to $75.9 million.
- Immunocore Holdings' Receivables rose 19.23% to $75.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $271.8 million, marking a year-over-year increase of 16.28%. This contributed to the annual value of $63.0 million for FY2024, which is 20.95% up from last year.
- Latest data reveals that Immunocore Holdings reported Receivables of $75.9 million as of Q3 2025, which was up 8.74% from $69.8 million recorded in Q2 2025.
- Over the past 5 years, Immunocore Holdings' Receivables peaked at $75.9 million during Q3 2025, and registered a low of $7.3 million during Q4 2021.
- Moreover, its 3-year median value for Receivables was $63.1 million (2024), whereas its average is $63.2 million.
- Data for Immunocore Holdings' Receivables shows a peak YoY spiked of 357.92% (in 2022) over the last 5 years.
- Immunocore Holdings' Receivables (Quarterly) stood at $7.3 million in 2021, then surged by 357.92% to $33.6 million in 2022, then spiked by 55.11% to $52.1 million in 2023, then grew by 20.95% to $63.0 million in 2024, then climbed by 19.23% to $75.9 million in 2025.
- Its Receivables stands at $75.9 million for Q3 2025, versus $69.8 million for Q2 2025 and $63.1 million for Q1 2025.